Neuroscience

The resilience of brain-training hype

It was definitely déjà vu in the media today. Reuters, The New Yorker, Los Angeles Times, and more were back on the "brain training prevents dementia" bandwagon.

Other

US sues to block $28 bn Amgen biopharma acquisition

US regulators filed a lawsuit Tuesday to block biopharmaceutical firm Amgen's proposed $28 billion takeover of drug maker Horizon Therapeutics, saying the transaction would harm consumers.

Other

US wants more information from Roche on Illumina bid

Swiss pharmaceutical group Roche said Tuesday the US Federal Trade Commission had requested additional information on its hostile $5.7-billion (4.2 billion euros) bid for US gene mapper Illumina.

Other

Pomegranate juice claims deceptive, US rules

Pomegranate juice has not been proven to be an effective treatment for cancer, heart disease or erectile dysfunction, US regulators said Monday, calling a company's ad claims deceptive.

page 4 from 9